1. Academic Validation
  2. S14-95, a novel inhibitor of the JAK/STAT pathway from a Penicillium species

S14-95, a novel inhibitor of the JAK/STAT pathway from a Penicillium species

  • J Antibiot (Tokyo). 2003 Apr;56(4):337-43. doi: 10.7164/antibiotics.56.337.
Gerhard Erkel 1 Jan Rether Timm Anke Olov Sterner
Affiliations

Affiliation

  • 1 Institut für Biotechnologie und Wirkstoff-Forschung e.V, Erwin-Schrödinger-Str. 56, D-67663 Kaiserslautern, Germany. [email protected]
Abstract

In a search for new inhibitors of the IFN-gamma mediated signal transduction in HeLa S3 cells using secreted Alkaline Phosphatase (SEAP) as reporter gene, a novel compound, designated as S14-95 was isolated from fermentations of the imperfect fungus Penicillium sp. 14-95. The compound inhibits the IFN-gamma mediated expression of the reporter gene with IC50 values of 2.5 to approximately 5 microg/ml (5.4 to approximately 10.8 microM). Furthermore the compound inhibited the expression of the proinflammatory enzymes COX-2 and NOS II at 5 microg/ml (10.8 microM) in LPS/IFN-gamma stimulated J774 mouse macrophages. Studies on the mode of action of the compound revealed that the inhibition of the IFN-gamma dependent signaling pathway is caused by an inhibition of the phosphorylation of the STAT1alpha transcription factor. In addition, S14-95 inhibited the activation of the p38 MAP kinase, which is involved in the inducible expression of many proinflammatory genes.

Figures
Products